“What is The Comparative Effectiveness of Targeted Therapy versus Immunotherapy in Terms of Overall Survival, Progression-free Survival, and Quality of Life For Patients With Metastatic Renal Cell Carcinoma? : A Systematic Review and Meta-Analysis ”, JOC, vol. 24, no. 10s, pp. 274–299, Nov. 2025, doi: 10.64149/J.Carcinog.24.10s.274-299.